These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17785835)

  • 21. A reduced antigen load in vivo, rather than weak inflammation, causes a substantial delay in CD8+ T cell priming against Mycobacterium bovis (bacillus Calmette-Guérin).
    Russell MS; Iskandar M; Mykytczuk OL; Nash JH; Krishnan L; Sad S
    J Immunol; 2007 Jul; 179(1):211-20. PubMed ID: 17579040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA vaccine with discontinuous T-cell epitope insertions into HSP65 scaffold as a potential means to improve immunogenicity of multi-epitope Mycobacterium tuberculosis vaccine.
    Wu M; Li M; Yue Y; Xu W
    Microbiol Immunol; 2016 Sep; 60(9):634-45. PubMed ID: 27531823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exposure to human alveolar lining fluid enhances Mycobacterium bovis BCG vaccine efficacy against Mycobacterium tuberculosis infection in a CD8
    Moliva JI; Hossfeld AP; Canan CH; Dwivedi V; Wewers MD; Beamer G; Turner J; Torrelles JB
    Mucosal Immunol; 2018 May; 11(3):968-978. PubMed ID: 28930287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ESAT-6-dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo.
    Kupz A; Zedler U; Stäber M; Perdomo C; Dorhoi A; Brosch R; Kaufmann SH
    J Clin Invest; 2016 Jun; 126(6):2109-22. PubMed ID: 27111234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suboptimal Antigen Presentation Contributes to Virulence of Mycobacterium tuberculosis In Vivo.
    Grace PS; Ernst JD
    J Immunol; 2016 Jan; 196(1):357-64. PubMed ID: 26573837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans.
    Geluk A; van Meijgaarden KE; Franken KL; Drijfhout JW; D'Souza S; Necker A; Huygen K; Ottenhoff TH
    J Immunol; 2000 Dec; 165(11):6463-71. PubMed ID: 11086086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity.
    Hoft DF; Blazevic A; Stanley J; Landry B; Sizemore D; Kpamegan E; Gearhart J; Scott A; Kik S; Pau MG; Goudsmit J; McClain JB; Sadoff J
    Vaccine; 2012 Mar; 30(12):2098-108. PubMed ID: 22296955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD8+-T-cell responses of Mycobacterium-infected mice to a newly identified major histocompatibility complex class I-restricted epitope shared by proteins of the ESAT-6 family.
    Majlessi L; Rojas MJ; Brodin P; Leclerc C
    Infect Immun; 2003 Dec; 71(12):7173-7. PubMed ID: 14638811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypical and functional analysis of memory and effector human CD8 T cells specific for mycobacterial antigens.
    Caccamo N; Meraviglia S; La Mendola C; Guggino G; Dieli F; Salerno A
    J Immunol; 2006 Aug; 177(3):1780-5. PubMed ID: 16849488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Classically restricted human CD8+ T lymphocytes derived from Mycobacterium tuberculosis-infected cells: definition of antigenic specificity.
    Lewinsohn DM; Zhu L; Madison VJ; Dillon DC; Fling SP; Reed SG; Grabstein KH; Alderson MR
    J Immunol; 2001 Jan; 166(1):439-46. PubMed ID: 11123322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis.
    Coler RN; Campos-Neto A; Ovendale P; Day FH; Fling SP; Zhu L; Serbina N; Flynn JL; Reed SG; Alderson MR
    J Immunol; 2001 May; 166(10):6227-35. PubMed ID: 11342645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
    Deng YH; He HY; Zhang FJ
    Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon.
    Radosevic K; Wieland CW; Rodriguez A; Weverling GJ; Mintardjo R; Gillissen G; Vogels R; Skeiky YA; Hone DM; Sadoff JC; van der Poll T; Havenga M; Goudsmit J
    Infect Immun; 2007 Aug; 75(8):4105-15. PubMed ID: 17526747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonal analysis of the T-cell response to in vivo expressed Mycobacterium tuberculosis protein Rv2034, using a CD154 expression based T-cell cloning method.
    Commandeur S; Coppola M; Dijkman K; Friggen AH; van Meijgaarden KE; van den Eeden SJ; Wilson L; van der Ploeg-van Schip JJ; Franken KL; Geluk A; Ottenhoff TH
    PLoS One; 2014; 9(6):e99203. PubMed ID: 24905579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human CD8+ CTL specific for the mycobacterial major secreted antigen 85A.
    Smith SM; Brookes R; Klein MR; Malin AS; Lukey PT; King AS; Ogg GS; Hill AV; Dockrell HM
    J Immunol; 2000 Dec; 165(12):7088-95. PubMed ID: 11120838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential pulmonary immunization with heterologous recombinant influenza A virus tuberculosis vaccines protects against murine M. tuberculosis infection.
    Muflihah H; Flórido M; Lin LCW; Xia Y; Triccas JA; Stambas J; Britton WJ
    Vaccine; 2018 Apr; 36(18):2462-2470. PubMed ID: 29602704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigen load governs the differential priming of CD8 T cells in response to the bacille Calmette Guerin vaccine or Mycobacterium tuberculosis infection.
    Ryan AA; Nambiar JK; Wozniak TM; Roediger B; Shklovskaya E; Britton WJ; Fazekas de St Groth B; Triccas JA
    J Immunol; 2009 Jun; 182(11):7172-7. PubMed ID: 19454714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epitope-specific CD4+, but not CD8+, T-cell responses induced by recombinant influenza A viruses protect against Mycobacterium tuberculosis infection.
    Flórido M; Pillay R; Gillis CM; Xia Y; Turner SJ; Triccas JA; Stambas J; Britton WJ
    Eur J Immunol; 2015 Mar; 45(3):780-93. PubMed ID: 25430701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity.
    Joosten SA; van Meijgaarden KE; van Weeren PC; Kazi F; Geluk A; Savage ND; Drijfhout JW; Flower DR; Hanekom WA; Klein MR; Ottenhoff TH
    PLoS Pathog; 2010 Feb; 6(2):e1000782. PubMed ID: 20195504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
    Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
    PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.